NEW YORK – MedGenome announced on Wednesday that it has received an investment of $55 million.
The genetic diagnostics, research, and data company — which focuses on expanding access to genetic testing for populations in South Asia and other emerging markets — said it will use the funding to expand its clinical genomic testing efforts into additional towns and cities in India, and to accelerate its drug discovery programs.